PL367957A1 - Zastosowanie kopolimeru do wytwarzania postaci leku zawierającej peptyd lub białko jako substancję czynną - Google Patents

Zastosowanie kopolimeru do wytwarzania postaci leku zawierającej peptyd lub białko jako substancję czynną

Info

Publication number
PL367957A1
PL367957A1 PL01367957A PL36795701A PL367957A1 PL 367957 A1 PL367957 A1 PL 367957A1 PL 01367957 A PL01367957 A PL 01367957A PL 36795701 A PL36795701 A PL 36795701A PL 367957 A1 PL367957 A1 PL 367957A1
Authority
PL
Poland
Prior art keywords
peptide
copolymer
protein
produce
active agent
Prior art date
Application number
PL01367957A
Other languages
English (en)
Inventor
Hans-Ulrich Petereit
Thomas Beckert
Original Assignee
Röhm Gmbh & Co.Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Röhm Gmbh & Co.Kg filed Critical Röhm Gmbh & Co.Kg
Publication of PL367957A1 publication Critical patent/PL367957A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL01367957A 2001-10-15 2001-10-15 Zastosowanie kopolimeru do wytwarzania postaci leku zawierającej peptyd lub białko jako substancję czynną PL367957A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2001/011899 WO2003032958A1 (de) 2001-10-15 2001-10-15 Verwendung eines copolymeren zur herstellung einer arzneiform, die als wirkstoff ein peptid oder protein enthält

Publications (1)

Publication Number Publication Date
PL367957A1 true PL367957A1 (pl) 2005-03-07

Family

ID=8164626

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01367957A PL367957A1 (pl) 2001-10-15 2001-10-15 Zastosowanie kopolimeru do wytwarzania postaci leku zawierającej peptyd lub białko jako substancję czynną

Country Status (12)

Country Link
US (1) US20030091637A1 (pl)
EP (1) EP1435922A1 (pl)
JP (1) JP2005506991A (pl)
KR (1) KR20040047915A (pl)
BR (1) BR0117149A (pl)
CA (1) CA2460132A1 (pl)
HU (1) HUP0401732A2 (pl)
IL (1) IL160190A0 (pl)
MX (1) MXPA04003540A (pl)
PL (1) PL367957A1 (pl)
SK (1) SK1732004A3 (pl)
WO (1) WO2003032958A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04010956A (es) 2003-01-30 2005-01-25 Roehm Gmbh Forma de dosis farmaceutica y metodo para la produccion de la misma.
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
DE10332160A1 (de) * 2003-07-15 2005-02-03 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
CN1826099B (zh) * 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
ATE301990T1 (de) 2003-07-25 2005-09-15 Ferring Bv Pharmazeutische desmopressin-zubereitung als feste darreichungsform und methode zu ihrer herstellung
US7018653B2 (en) * 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
CA2490601C (en) * 2003-12-29 2006-05-02 Ferring B.V. Method for preparing solid dosage form of desmopressin
PT1550439E (pt) * 2003-12-29 2006-06-30 Ferring Bv Metodo para a preparacao de uma forma solida de dosagem de desmopressina
DK1883396T3 (da) 2005-05-18 2013-10-07 Centre Nat Rech Scient Afgivelse af adsorptionsmidler til tyktarmen
DE102005024614A1 (de) * 2005-05-25 2006-11-30 Röhm Gmbh Verwendung von Polymermischungen zur Herstellung von überzogenen Arzneiformen sowie Arzneiform mit polymerem Mischüberzug
US8048413B2 (en) 2006-05-17 2011-11-01 Helene Huguet Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
US8268356B2 (en) * 2007-11-16 2012-09-18 Asahi Kasei Chemicals Corporation Aqueous film coating solution, film coated granule and tablet using the same
US10265384B2 (en) * 2015-01-29 2019-04-23 Novo Nordisk A/S Tablets comprising GLP-1 agonist and enteric coating

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208465A (en) * 1978-05-03 1980-06-17 E. I. Du Pont De Nemours And Company Clear coat/color coat finish containing an antioxidant and an ultraviolet light stabilizer
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
DE3405378A1 (de) * 1984-02-15 1985-08-22 Röhm GmbH, 6100 Darmstadt Arzneimittelueberzug
DE3524337A1 (de) * 1985-07-08 1987-01-08 Roehm Gmbh Arzneimittelumhuellung
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
US5032405A (en) * 1989-09-27 1991-07-16 Warner-Lambert Company Oral pharmaceutical composition for acid sensitive proteinaceous agents
DE4026992A1 (de) * 1990-08-25 1992-02-27 Roehm Gmbh Verfahren zur herstellung von traegersystemen fuer biologisch aktive materialien
ES2109362T3 (es) * 1991-06-21 1998-01-16 Univ Cincinnati Unas proteinas administrables oralmente y metodo para hacerlas.
SG52402A1 (en) * 1992-12-22 1998-09-28 Univ Cincinnati Oral administration of immunologically active biomolecules and other therapeutic proteins
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
DE9414065U1 (de) * 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Thermoplastischer Kunststoff für darmsaftlösliche Arznei-Umhüllungen
DE9414066U1 (de) * 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform
DE19653606A1 (de) * 1996-12-20 1998-06-25 Roehm Gmbh Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher
DE19715794C1 (de) * 1997-04-16 1998-12-03 Roehm Gmbh Laminare Arzneiform und Verfahren zu ihrer Herstellung
AU783099B2 (en) * 2000-01-07 2005-09-22 Rohm Gmbh & Co. Kg Selective activation of a TH1 or TH2 lymphocyte regulated immune response

Also Published As

Publication number Publication date
JP2005506991A (ja) 2005-03-10
KR20040047915A (ko) 2004-06-05
MXPA04003540A (es) 2004-07-22
WO2003032958A1 (de) 2003-04-24
SK1732004A3 (sk) 2005-06-02
CA2460132A1 (en) 2003-04-24
US20030091637A1 (en) 2003-05-15
EP1435922A1 (de) 2004-07-14
HUP0401732A2 (hu) 2004-12-28
BR0117149A (pt) 2004-11-23
IL160190A0 (en) 2004-07-25

Similar Documents

Publication Publication Date Title
IL163552A (en) Conjugates of biologically active compounds, uses thereof and pharmaceutical compositions comprising the same
AU2000279625A1 (en) Blood mmp-3 level-lowering agent containing il-6 antgonist as the active ingredient
HUP0500456A3 (en) Hepatitis c tripeptide inhibitors, pharmaceutical compositions comprising thereof and their use
GB0012850D0 (en) Cyclic amino acid derivatives useful as pharmaceutical agents
HUP0400384A3 (en) Benzamidine derivative and pharmaceutical compositions containing them and their use
IL150756A0 (en) Novel use of hiv proteins
AU2001294515A1 (en) Use of stat-6 inhibitors as therapeutic agents
AU2002364893A8 (en) Delivery of medicaments to the nail
AU2002335046A1 (en) The use of proton sequestering agents in drug formulations
HUP0302508A3 (en) Pyridazinones and triazinones and their use as active ingredients of pharmaceutical compositions
HUP0400548A3 (en) Use of combinations of iop-reducing active inoredient for preparation of pharmaceutical compositions available for treatment glaucoma
IL160190A0 (en) Use of copolymer to produce a galenic form containining a peptide or a protein as active agent
HUP0402318A3 (en) Pharmaceutical composition comprising cyclosporin and use thereof
WO2003020200A3 (en) A novel pharmaceutical compound and methods of making and using same
HUP0303636A3 (en) Dihydronaphthalenederivative compounds and pharmaceutical compositions containing them as active ingredient
AU2003241103A8 (en) Compositions containing anti-hiv peptides and methods of use
AU8799001A (en) Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases
HUP0401773A3 (en) Use of [(2-amino-3,4-dioxo-1cyclobuten-1-yl)amino]alkanacid derivatives for the preparation pharmaceutical compositions usable for treatment of pain
AU2001265280A1 (en) Preparation of 2-hydroxy-5-oxoproline and analogs thereof
HUP0302535A3 (en) Peptide compounds, pharmaceutical compositions containing them and their use for treatment of no-mediated diseases
AU2001277696A1 (en) Novel physiologically active peptide and use thereof
AU2002221684A1 (en) Use of a copolymer to produce a galenic form containing a peptide or a protein as active agent
HK1067541A (en) Use of a copolymer to produce a galenic form containing a peptide or a protein as active agent
EP1275657A4 (en) PEPTIDE DERIVATIVES AND MEDICINAL COMPOSITIONS
AU2002230129A1 (en) Novel physiologically active peptide and use thereof

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)